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IsmailiaAbstract Background: Tuberculosis (TB) is a major cause of illness and death worldwide, espe-
cially in Asia and Africa. In the early 1990s tuberculosis control in Egypt faced many problems.
Major progress in global tuberculosis control followed the widespread implementation of the
DOTS strategy.
Aim: The objective of this work was to study the tuberculosis situation in the Ismailia gover-
norate from 2002 to 2012 before and after Direct Observed Therapy Short Course Strategy
(DOTS).
Methods: This was a retrospective clinical cohort study carried out at the Ismailia governorate.
The registered data about all TB cases over a period of 10 years (2002–2012) before and after the
application of DOTS were collected from the chest hospital and TB registration units.
Percentages of cure treatment significantly increased after DOTS (55.3%) than before (40.5%)
(P< 0.01). On the other hand, complete, failure, death, default and transfer out decreased after
DOTS (32.5%, 1.3%, 6.3%, 2.5% and 2.0% respectively) than before it (38.7%, 3.1%, 6.9%,
7.2% and 4.0% respectively), the results were not significant (P> 0.05) for all of them.
The mean values of incidence rates (new and relapse cases, all cases and new smear positive
pulmonary TB cases) of TB highly significantly (P< 0.01) decreased after the application of
DOTS for all of them except new smear positive pulmonary TB cases (P> 0.05). Also, the
cure rate and treatment success rate significantly increased (P< 0.05), while retreatment TB
cases rate, default rate, transfer out rate and retreatment failure rate did not significantly
decreased (P> 0.05) for all of them except retreatment failure rate (chronic TB rate)
(P< 0.05). Finally new pulmonary TB cases with no smear result significantly (P< 0.05)
decreased after DOTS.
212 M.F. Negm et al.Conclusion: The introduction of DOTS in the Ismailia governorate has led to a significant
increase in the treatment success (88.07%) which is higher than the WHO target (85%), and
a decrease in the default and failure rates.
 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Tuberculosis (TB) is an infectious disease that remains a
major global health problem. It causes ill-health among mil-
lions of people each year and ranks as the second leading
cause of death from an infectious disease worldwide, after
the human immune-deficiency virus (HIV). In the latest
estimates there were 8.6 million new TB cases in 2012 and
1.3 million TB deaths [15]. Most of the estimated numbers
of TB cases in 2009 occurred in Asia (55%) and Africa
(30%), with India and China combined accounted for 35%
of all TB cases. The 22 high-burden countries (HBCs)
that have received the particular attention at the global level
since 2000 accounted for 80% of all estimated TB cases
worldwide [15].
World Health Organization (WHO) has set the interna-
tional target value for a treatment success outcome at 85%
however the world wide success rates for tuberculosis range
from 20% to 87% [7].
The DOTS guidelines recommend a short course regimen
for newly diagnosed patients whose sputum shows smear pos-
itive results, which start with an intensive phase of four drugs
(isoniazid, rifampicin, pyrazinamide and ethambutol) for two
months followed by a continuation phase of rifampicin and
isoniazid for four months, all given under direct observation
of treatment [5].
Under DOTS, treatment may be given daily or three times
weekly for both treatment phases. Additionally, in the inten-
sive phase ethambutol may be replaced by the injectable strep-
tomycin [13].
DOTS strategy has five key components as identified by WHO
Government commitment to sustained tuberculosis control
activities includes case detection by sputum smears microscopy
among symptomatic patients, standardized treatment regimen
of 6–8 months for all confirmed sputum smear positive cases
with DOTS for at least the initial 2 months, a regular UN
interrupted supply of all essential anti-tuberculosis drugs,
standardized recording and reporting system that allows
assessment of treatment [12].
The primary key of DOTS strategy is the direct observation
of tuberculosis treatment (DOT) by a supervisor, usually a
health or community worker supervising TB patients to ensure
they are taking their medications thus decreasing prolonged
morbidity and drug resistance [2].
To date DOTS strategy remains the corner stone of global
efforts for tuberculosis control and studies throughout the
world indicate that by using DOTS strategy, the success rate
of treatment is about 90–95% or even higher [7].
Microbial resistance to anti-tuberculosis drugs has existed
since the dawn of the antibiotic era. Multidrug-resistant(MDR) tuberculosis defined by resistance to isoniazid
and rifampicin, requires treatment for up to two years with
expensive second line drugs and success rates rarely exceed
65–75%. Extensively drug-resistant(XDR) tuberculosis, refers
to the disease caused by multidrug-resistant strains that are
also resistant to treatment with any fluoroquinolone and
any of the injectable drugs used in treatment with second-
line anti-tuberculosis drugs (amikacin, capreomycin and
kanamycin) [10].Aim
The objective of this work was to study the tuberculosis situa-
tion in the Ismailia governorate from 2002 to 2012 before and
after the application of Direct Observed Therapy Short Course
Strategy (DOTS).Methodology
This was a retrospective clinical cohort study carried out at the
Ismailia governorate. The registered data about all TB cases
over a period of 10 years (2002–2012) were collected from
the TB registration units in the Ismailia governorate. This
period includes 2 stages; four years (2002–2006) before the
application of DOTS and six years (2007–2012) after it.
– The Collected data included:
(1) TB registration code and the year.
(2) Socio demographic data which included name, age, sex
and residence.
(3) Forms of tuberculosis; Either: Pulmonary (either smear
positive or smear negative) or extra pulmonary (and its
site as LN, intestine, meninges, breast, renal).
(4) History of previous treatment if present (category of
patients or type of the patient); either new, relapse, treat-
ment after failure, treatment after default, transfer in or
others.
(5) Schedule of treatment (recommended standardized treat-
ment regimen) according to [8].
(6) The recorded follow up for smear-positive pulmonary
tuberculosis included sputum smear microscopic exami-
nation for acid fast bacilli, at the end of 2nd month, at
end of 5th month and at the end of treatment [8].
(7) Outcome: which included: Cure, treatment completed,
treatment failure, died, default and transfer out.
(8) Culture result: The total number of cases examined
yearly by culture and its result.
– TB indicators were designed by The World Health Orga-
nization [14] to determine national TB program (NTP)
quality and effectiveness , these indicators are:
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new and relapse cases, all cases and new smear positive
pulmonary cases.
 New pulmonary TB cases with no smear result.
 New adult smear positive cases.
 Re-treatment TB cases.
 New extra pulmonary TB cases.
 New TB cases with no smear conversion result.
 Sputum conversion rate at the end of the initial phase of
treatment.
 Cure rate.
 Treatment completion rate.
 Death rate.
 Treatment failure rate.
 Default rate.
 Transfer out rate.
 Re-treatment failure rate (chronic TB rate).
– Comparison of indicators before and after DOTS was car-
ried out.
Statistical analysis
The collected data were tabulated and analyzed using SPSS
version 16 software, categorical data were presented as number
and percentages while continuous variables were presented as
mean and standard deviation. Chi square test, Fisher’s exact
test and Student ‘‘t” test were used. Microstat software was
used to calculate ‘‘Z” test for 2 proportions of 2 independent
groups. P< 0.05 was considered significant.
Results
The majority (38.0%) of the studied patients were between 15
and less than 30 years old. The highest percentage (68.0%) was
males and 89.0% were from urban areas Table 1.Table 1 Socio-demographic characters of the studied sample.
Variable Total
(N= 1363)
%
100.0
Locality Eltal elkabeer 64 5.0
Elkasasen 80 6.0
Abo-suer 115 8.0
Ismailia 855 63.0
Faied 72 5.0
Elkantara shark 67 5.0
Elkantara gharb 110 8.0
The studied
patients
Before DOTS (2002–2006) 763 56.0
After DOTS (2007–2012) 600 44.0
Age <15 117 9.0
15 513 38.0
30 372 27.0
45 247 18.0
60+ 114 8.0
Gender Male 924 68.0
Female 439 32.0
Residence Urban 1216 89.0
Rural 147 11.0There was a statistically significant difference (P< 0.01)
regarding the socio-demographic characters of patients before
and after the application of the program, where, infection
among younger ages (15 and 30) decreased (11.1% and
38.0% before DOTS and 5.3% and 37.2% after DOTS). The
percentage of infected males was lower after DOTS than
before (64% and 72.5% respectively). Infection among rural
residents also became lower after DOTS than before (9.7%
and 11.7% respectively) Table 2.
Results showed also that percentage of pulmonary TB was
lower after the application of DOTS (83.3%) than before
(89.0%). Regarding the smear results at diagnosis, it was
52.7% before DOTS and became 66.3% after. The percentages
of smear ve cases at 2nd, 3rd, and 5th month and end of
treatment were lower after DOTS than before (96.0%,
76.4%, 47.5% and 14.5% respectively after DOTS and
(92.5%, 75.0%, 37.7% and 8.8% respectively before DOTS).
All these differences were statistically significant (P= 0.001)
for all. The table also shows that culture was done for only
1.2% of the studied patients Table 3.
This work found that the relapse did not significantly
(P> 0.05) decrease after the application of DOTS. Regarding
treatment outcome, it showed that the percentages of cure
treatment highly significantly increase after DOTS (55.3%)
than before (40.5%) (P> 0.01). On the other hand, complete,
failure, death, default and transfer out did not significantly
decrease (P> 0.05) after DOTS (32.5%, 1.3%, 6.3%, 2.5%
and 2.0% respectively) than before DOTS (38.7%, 3.1%,
6.9%, 7.2% and 4.0% respectively) in Table 4.
The mean values of incidence rates (new and relapse cases,
all cases) of TB highly significantly (P< 0.01) decreased after
the application of DOTS except for the incidence rate of new
smear positive pulmonary TB cases (P> 0.05). Also, the cure
rate and treatment success rate did not significantly increase
(P> 0.05), and so default rate, transfer out rate and treatment
failure rate did not significantly decrease (P> 0.05) except for
the retreatment failure (chronic TB cases rate) (P< 0.05)
Finally new pulmonary TB cases with no smear result signifi-
cantly (P< 0.05) decreased after DOTS Table 5.Discussion
This study investigated the situation of tuberculosis in the
Ismailia governorate from January 2002 to December 2012,
before and after the application of Direct Observed Therapy
Short Course Strategy (DOTS). The total number of the
recorded tuberculous cases was 1363; 763 cases before DOTS
and 600 cases after.
This work revealed that the highest prevalence (by age) of
TB was among individuals aged 15< 30 years (38.0%),
and the lowest prevalence was among those of age extremes.
This could be explained by the increased prevalence of
smoking behavior among this active age group in our society.
Moreover, poverty, malnutrition, physical, mental, and
occupational stress and more exposure to infection are other
contributing factors. El-Zeheiry [3], conducted a retrospective
study in the Dakahlia governorate, Egypt to review the TB
situation, she found that tuberculosis was common among
the middle aged group from 15< 30 years (32.3%). Simi-
lar results were drawn in the El-Menoufia governorate
(1992–2008) Abdelghany [1], and in El-Gharbia governorate
Table 2 Socio-demographic characters of the studied patients before and after the application of DOTS.
Variable Before DOTS (N= 763) After DOTS (N= 600) Total (N= 1363) v2 P
No % No % No %
Age <15 85 11.1 32 5.3 117 8.6 19.6 0.001**
15 290 38.0 223 37.2 513 37.6
30 204 26.7 168 28.0 372 27.3
45 119 15.6 128 21.3 247 18.1
60+ 65 8.5 49 8.2 114 8.4
Gender Male 489 64.0 435 72.5 924 68.0 10.88 0.001**
Female 274 36.0 165 27.5 439 32.0
Residence Urban 674 88.3 542 90.3 1216 89.0 1.39 0.24
Rural 89 11.7 58 9.7 147 11.0
Table 3 Site, smear and culture results among the studied patients before and after the application of DOTS.
Variable Before DOTS
(N= 763)
After DOTS
(N= 600)
Total
(N= 1363)
v2 P
No % No % No %
Site of TB Pulmonary 679 89.0 500 83.3 1179 86.5 9.21 0.002**
Extra pulmonary 84 11.0 100 16.7 184 13.5
Sputum smear at diagnosis +ve 402 52.7 398 66.3 800 58.7 25.8 0.001**
ve 361 47.3 202 33.7 563 41.3
(N= 402) (N= 398) (N= 800)
Sputum smear at 2nd my +ve 28 7.0 11 2.8 39 4.9 8.81 0.012*
ve 372 92.5 382 96.0 754 94.2
Not done 2 0.5 5 1.2 7 0.9
Sputum smear at 3rd my +ve 20 5.0 9 2.3 29 3.6 4.31 0.116
ve 302 75.0 304 76.4 606 75.8
Not done 80 20.0 85 21.3 165 20.6
(N= 763) (N= 600) (N= 1363)
Sputum smear at 5th m* +ve 15 2.0 8 1.3 23 1.7 13.36 0.001**
ve 288 37.7 285 47.5 573 42.0
Dropouts 460 60.3 307 51.2 767 56.3
Sputum smear at end treatmenty +ve 9 1.2 1 0.2 10 0.7 15.27 0.001**
ve 67 8.8 87 14.5 154 11.3
Dropouts 687 90.0 512 85.3 1199 88.0
Culture results +ve 1 0.1 6 1.0 7 0.5 7.77 0.02*
-ve 3 0.4 7 1.2 10 0.7
Not done 759 99.5 587 97.8 1346 98.8
y Among the smear positive cases at diagnosis.
214 M.F. Negm et al.(1994–2010) where the highest prevalence of TB occurred
among the age group 15< 30 years (34.72%), (33.7%),
respectively and the lowest prevalence occurred in extremes
of age [4]. In the present study, tuberculosis was common
among men (67.8%) than women (32.2%). This could be
explained by the fact that males are more active and are
exposed to stress more than females. Also, many females
may not seek medical advice due to factors related to illiteracy,
cultural and traditional attitudes which may neglect the
females’ health status. Higher tuberculosis notification rates
among men may partly indicate differences in exposure due
to more frequent social contacts, risk of infection and progres-
sion from infection to disease caused by gender differences in
association with other risk factors for tuberculosis such asalcohol abuse and smoking which are associated with pul-
monary tuberculosis. Similar results were obtained by Floyd
et al. [6], they found that male cases were 80.2% and female
cases were 19.8%.
Urban cases (89.0%) were higher than rural cases (11%).
Increased tuberculous cases in urban areas could be explained
by what is reported by, [9] who conducted a study about costs
and outcomes of tuberculosis in the Russian Federation, they
found that urban cases (80.8%) were significantly higher than
rural cases (19.2%). They explained this result by demographic
changes like increasing life expectancy, population growth, and
deterioration of living conditions in urban areas like over-
crowding and epidemiological factors like HIV epidemics. Also
it may be due to the shift of people from rural to urban areas.
Table 4 Type of patient and treatment outcome among the studied sample before and after the application of DOTS.
Variable Before DOTS (763) After DOTS (600) Total (1363) Z P
No % No % No %
Type of patients New 683 89.5 547 91.2 1230 90.2 4.21 0.001 HS (<0.01)
Relapse 40 5.2 36 6.0 76 5.6 0.459 0.323 NS
Failure 10 1.3 7 1.2 17 1.2 0.0 0.5 NS
Defaulter 11 1.4 7 1.6 18 1.3 0.218 0.414 NS (>0.05)
Transfer 10 1.3 0 0.0 10 0.7 – –
Others* 9 1.2 3 0.5 12 0.9 0.504 0.307 NS
Treatment outcome Cure§ 309 40.5 332 55.3 641 47.0 0.909 0.001 HS
Complete 295 38.7 195 32.5 490 36.0 7.75 0.05 NS
Fail 23 3.1 8 1.3 31 2.3 0.541 0.29 NS
Death 53 6.9 38 6.3 91 6.7 1.59 0.055 NS
Default 55 7.2 15 2.5 70 5.1 0.0 0.5 NS
Transfer out 28 3.7 12 2.0 40 2.9 0.96 0.17 NS
*Others groups include: chronic cases, patients who are sputum positive at the end of a re-treatment regimen.
§ For smear positive cases.
Table 5 Tuberculosis indices before and after the application of DOTS.
Indices Before DOTS After DOTS T test P* Statistical
significance
Mean
Indicator
Mean
before
DOTS
SD Mean
after
DOTS
SD
1 Incidence rate: new cases 12.22 1.72 8.01 1.72 4.04 0.003 HS (<0.01)
2 Incidence rate: new and relapse cases 12.98 1.87 8.55 2.01 3.75 0.005 HS
3 Incidence rate: all cases 13.66 1.85 8.95 2.1 3.9 0.004 HS
4 Incidence rate new smear positive pulmonary TB cases 5.96 1.11 5.07 0.96 1.42 0.189 NS
5 New pulmonary TB cases with no smear result 30.82 5.48 19.1 7.31 2.95 0.016 S
6 New adult smear positive cases 54.75 8.15 72.76 13.83 2.55 0.031 S
7 Retreatment TB cases 10.5 2.65 10.24 3.61 0.132 0.898 NS (>0.05)
8 New extrapulmonary TB cases 21.36 1.41 19.03 4.24 1.16 0.274 NS
9 New TB cases with no smear conversion result 5.74 2.68 3.35 1.89 1.74 0.116 NS
10 Sputum conversion rate at the end of the initial phase of treatment 69.73 16.53 80.23 4.08 1.52 0.164 NS
11 Cure rate 80.39 8.24 87.23 2.74 1.93 0.086 NS
12 Treatment completion rate 6.48 5.44 0.84 0.93 2.52 0.033 S
13 Treatment success rate 86.87 3.43 88.07 3.0 0.618 0.552 NS
14 Death rate 4.78 3.09 4.29 2.16 0.315 0.76 NS
15 Treatment failure rate 2.81 3.82 2.57 1.11 *Z= 0.55 0.582 NS
16 Default rate 4.78 1.19 3.55 1.62 1.41 0.193 NS
17 Transfer out rate 0.75 1.04 1.52 1.74 *Z = 0.896 0.37 NS
18 Retreatment failure rate (chronic TB rate) 10.25 7.48 1.19 2.91 *Z = 2.29 0.022 S
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Gharbia governorate (1994–2010), that stated that rural cases
(61.7%) were significantly higher in comparison with urban
cases (38.3%). Abdelghany [1], conducted a similar study in
the Menoufia governorate (1992–2008), he concluded that
rural cases (80.05%) were also significantly higher than urban
cases (19.95%) during all years of the study. Similar findings
have been reported by El-Zeheiry [3], in Dakahlia governorate
(2006–2011). Increased tuberculous cases in rural areas could
be explained by poverty and bad social conditions and milk
sanitation, also agricultural workers may acquire occupational
infection by bovine bacilli from the infected animals. More-
over, it may be due to better notification of rural cases due
to improved access to health care through decentralization ofthe services and improved patient follow up with the introduc-
tion of DOTS [11].
The current study revealed that infection among younger
ages (15 and 30) mildly decreased (11.1% and 38.0% before
DOTS and 5.3% and 37.2% after DOTS respectively). The per-
centage of infected males was not significantly decreased after
DOTS than before (72.5% and 64% respectively) (P> 0.05).
Infection among rural residents also became lower after DOTS
than before (9.7 and 11.7%, respectively) (Table 2). These find-
ings reflect the changes that occurred in the socio demographic
characters among patients, where the proportion of the
younger age group decreased, males became less infected and
improvement in the health services in rural areas led to a reduc-
tion in the percentage of the affected rural individuals.
216 M.F. Negm et al.In the present study there was an increase in extra pul-
monary cases (from 11.0% to 16.7%) with a decrease in pul-
monary cases (from 89% to 83.3%) before and after DOTS
respectively (Table 3). This indicates more control of the pul-
monary cases. Moreover, the increase in the extra pulmonary
cases may be a false increase explained by more availability
of diagnostic facilities such as specified X-rays or biopsy pro-
cedures which are necessary to detect extra pulmonary tuber-
culosis. Increased life expectancy which may be associated
with reactivation of a latent tuberculous lesion from pul-
monary sites and more physical contact with infected animals
may also be implicated.
This work reported that the sputum conversion rate
increased after DOTS at the end of the second month, third
month, fifth month and at the end of the treatment (Table 3).
This reflects more treatment success that is due to new regi-
mens of treatment with Rifampicin for six months, direct
observation of cases under treatment and good follow up of
patients. These results agree with [1,3,4]. The increase in the
conversion rate in this study and all the mentioned studies
means high efficacy of applying DOTS in chest hospitals and
dispensaries. There is also an increase in the number of cases
examined for their sputum.
As diagnosis of tuberculous cases depends mainly on direct
smear examination of sputum by Z.N. staining, the role of cul-
ture in diagnosis of cases was limited. As shown in this study
the number of cases examined by culture technique all over
the years was only 17 (1.2%) (Table 3). Similar findings have
been obtained by [1,4]. Lack of culture and sensitivity test
use at the studied chest units may be due to that the indications
of culture in DOTS include only; failure of re-treatment cases,
seriously ill cases, extra pulmonary cases, smear negative cases,
childhood TB and HIV-TB, for multidrug resistant TB (MDR
TB), not for new smear positive cases [13].
The comparison between the type of patient based on pre-
vious history of treatment before and after DOTS showed a
statistically significant increase in the new cases (Table 4).
The increased percentage of new cases after DOTS indicates
the efficacy of diagnosis and early detection of tuberculosis.
Also, it was found that Failure cases decreased after DOTS,
this result denotes the efficacy of applying DOTS, efficacy of
treatment and attendance of patients to take their treatment
regularly.
This study revealed that the most common type of patients
was new cases, which coincide with [1,3,4], who found that new
cases represented the highest percentage of cases attended for
treatment.
This study showed a significant improvement in all param-
eters of treatment outcome (expect for treatment failure) after
DOTS, which means a good impact of applying DOTS in the
chest hospitals and dispensaries. There was a marked decrease
in the percentage of defaulters which constitutes a great prob-
lem during tuberculosis treatment. Treatment failure may be
due to poor compliance of the patient or to practitioner error,
e.g. in cases where inadequate regimens and or shortened peri-
ods of treatment are prescribed. Drug resistance may also be
implicated. Unsuccessful treatment may result from irregular-
ity in taking treatment and loss of follow up, which may be due
to patients being transferred to another unit. Moreover, many
patients stop treatment as soon as they feel better.
The current research declared that the mean values of
incidence rates (new and relapse cases, all cases and new smearpositive pulmonary TB cases) of TB were significantly
(P< 0.05) decreased after the application of DOTS.
Also, the cure rate and treatment success rate did not
significantly increase (P> 0.05), while retreatment TB cases
rate, default rate, transfer out rate did not significantly
decrease (P> 0.05) but the retreatment failure TB cases
significantly decreased (P< 0.05), and finally new pulmonary
TB cases with no smear result significantly (P< 0.05)
decreased after DOTS (Table 5). Increased coverage by short
course chemotherapy, improved access to care through
decentralization of the service and improved patient follow-
up with the introduction of DOTS was observed that most
likely played a significant role in improving the treatment
outcomes.
Limitation of the study
Although this success of DOTS was seen there are points of
weakness in the Ismailia governorate Chest hospital; the high
percentage of sputum negative cases (17.2%) may be false
due to the decrease in the facilities of diagnosis in the gover-
norate hospitals. 2.9% of tuberculous cases were transferred
out, we have no idea about the outcome of these groups. Fewer
culture results were registered about TB cases.
Conclusion
The introduction of DOTS in the Ismailia governorate has led
to a significant increase in treatment success (88.07%) which is
higher than the WHO target (85%), and a decrease in default
and failure rates.
Recommendations
Poor patient knowledge regarding tuberculosis may be a sig-
nificant predictor of treatment failure, so strengthening health
education in the DOTS strategy is therefore recommended.
Patients with tuberculosis need more and more social and psy-
chological support to decrease defaulters and treatment fail-
ure. A special registration system for the transfer out cases
using a computer system with their national numbers is needed
to trace the outcome of these cases.
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